Madrigal Pharmaceuticals, Inc. (MDGL) - Latest Market Data

Price & Market Data

Price: $511.9

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $11,742,740,480

Daily Volume: 0

Performance Metrics

1 Week: 1.30%

1 Month: 18.27%

3 Months: -13.00%

6 Months: 15.55%

1 Year: 64.85%

YTD: -12.10%

Company Details

Employees: 915

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Selected stocks

Host Hotels & Resorts, Inc. (HST)

Capital Clean Energy Carriers Corp. (CCEC)

Burke & Herbert Financial Services Corp. (BHRB)